Boston Scientific rises, analysts see forecast cut as reset for investors

Boston Scientific

22/04/2026 16:00

** Shares of medical device maker Boston Scientific BSX.N rise 9.6% to $65.21, snapping a two-day losing streak

** Stock set for its biggest percentage jump in over 6 years, if gains hold

** Firm lowers its annual EPS forecast to $3.34-$3.41 from $3.43-$3.49

** Analysts on an average were expecting $3.45 - data compiled by LSEG

** BSX cuts its full-year organic revenue growth forecast to 6.5%-8% from 10%-11%

** RBC Capital Markets analysts call the cuts broadly anticipated and "somewhat of a relief"

** "This could/should hopefully be the reset investors wanted" - J.P. Morgan analyst Robbie Marcus

** Q1 adjusted EPS of 80 cents beat estimate of 79 cents - LSEG data

** Including session's move, BSX shares down 31.8% YTD

 (Reporting by Kunal Das in Bengaluru)

 ((Kunal.Das2@thomsonreuters.com;))